These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 3928675

  • 1. Long term treatment of Graves' hyperthyroidism with sodium ipodate.
    Shen DC, Wu SY, Chopra IJ, Huang HW, Shian LR, Bian TY, Jeng CY, Solomon DH.
    J Clin Endocrinol Metab; 1985 Oct; 61(4):723-7. PubMed ID: 3928675
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Further studies on the long-term treatment of Graves' hyperthyroidism with ipodate: assessment of a minimal effective dose.
    Shen DC, Wu SY, Chopra IJ, Shian LR, Florsheim W, Solomon DH.
    Thyroid; 1991 Oct; 1(2):143-6. PubMed ID: 1822359
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of hyperthyroidism with sodium ipodate (oragrafin) in addition to propylthiouracil and propranolol.
    Sharp B, Reed AW, Tamagra EI, Geffner DL, Hershman JM.
    J Clin Endocrinol Metab; 1981 Sep; 53(3):622-5. PubMed ID: 6894929
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease.
    Roti E, Robuschi G, Manfredi A, D'Amato L, Gardini E, Salvi M, Montermini M, Barlli AL, Gnudi A, Braverman LE.
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):489-96. PubMed ID: 3838710
    [Abstract] [Full Text] [Related]

  • 7. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).
    Chopra IJ, Williams DE, Orgiazzi J, Solomon DH.
    J Clin Endocrinol Metab; 1975 Nov; 41(5):911-20. PubMed ID: 1242390
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.
    Andrade VA, Gross JL, Maia AL.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4012-6. PubMed ID: 10566642
    [Abstract] [Full Text] [Related]

  • 10. Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease.
    Roti E, Robuschi G, Gardini E, Montermini M, Salvi M, Manfredi A, Gnudi A, Braverman LE.
    Clin Endocrinol (Oxf); 1988 Mar; 28(3):305-14. PubMed ID: 3168311
    [Abstract] [Full Text] [Related]

  • 11. Effect of the combination of dexamethasone and sodium ipodate on serum thyroid hormones in Graves' disease.
    Arteaga E, López JM, Rodríguez JA, Michaud P, López G.
    Clin Endocrinol (Oxf); 1983 Nov; 19(5):619-27. PubMed ID: 6688973
    [Abstract] [Full Text] [Related]

  • 12. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ, Ladenson PW.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sodium ipodate in the treatment of toxic diffuse goiter. Short-term and long-term effects on thyrotoxicosis.
    Kamel N, Uysal AR, Koloğlu S, Erdoğan G, Senel M, Polat H.
    Endocrinologie; 1988 Jul; 26(2):99-105. PubMed ID: 3413443
    [Abstract] [Full Text] [Related]

  • 16. Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis.
    Chopra IJ, van Herle AJ, Korenman SG, Viosca S, Younai S.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2178-80. PubMed ID: 7608275
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves' disease.
    Robuschi G, Manfredi A, Salvi M, Gardini E, Montermini M, d'Amato L, Borciani E, Negrotti L, Gnudi A, Roti E.
    J Endocrinol Invest; 1986 Aug; 9(4):287-91. PubMed ID: 3537101
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3.
    Burman KD, Dimond RC, Earll JM, Wright FD, Wartofsky L.
    J Clin Endocrinol Metab; 1976 Sep; 43(3):606-13. PubMed ID: 989049
    [Abstract] [Full Text] [Related]

  • 20. Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease.
    Takamatsu J, Kuma K, Mozai T.
    J Clin Endocrinol Metab; 1986 May; 62(5):980-3. PubMed ID: 3754263
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.